Found: 34
Select item for more details and to access through your institution.
Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97106-9
- By:
- Publication type:
- Article
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27928-8
- By:
- Publication type:
- Article
Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 2, p. 148, doi. 10.1007/s12185-014-1721-9
- By:
- Publication type:
- Article
JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 5, p. 625, doi. 10.1007/s12185-014-1567-1
- By:
- Publication type:
- Article
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27928-8
- By:
- Publication type:
- Article
Causes of Thrombocytosis: A Single-center Retrospective Study of 1,202 Patients.
- Published in:
- Internal Medicine, 2022, v. 61, n. 22, p. 3323, doi. 10.2169/internalmedicine.9282-21
- By:
- Publication type:
- Article
Impact of non‐driver gene mutations on thrombo‐haemorrhagic events in ET patients.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 221, doi. 10.1111/bjh.19177
- By:
- Publication type:
- Article
JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. e27, doi. 10.1111/bjh.16146
- By:
- Publication type:
- Article
Skewed megakaryopoiesis in human induced pluripotent stem cell‐derived haematopoietic progenitor cells harbouring calreticulin mutations.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 6, p. 791, doi. 10.1111/bjh.15266
- By:
- Publication type:
- Article
Dysregulation of the MIRLET7/ HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 3, p. 338, doi. 10.1111/bjh.13129
- By:
- Publication type:
- Article
Identification of AIM2 as a downstream target of JAK2V617F.
- Published in:
- Experimental Hematology & Oncology, 2016, v. 5, p. 1, doi. 10.1186/s40164-016-0032-7
- By:
- Publication type:
- Article
Melting Curve Analysis after T Allele Enrichment (MelcaTle) as a Highly Sensitive and Reliable Method for Detecting the JAK2V617F Mutation.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0122003
- By:
- Publication type:
- Article
Detection of <i>MPL</i>W515L/K Mutations and Determination of Allele Frequencies with a Single-Tube PCR Assay.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104958
- By:
- Publication type:
- Article
Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0057633
- By:
- Publication type:
- Article
In silico- labeled ghost cytometry.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.67660
- By:
- Publication type:
- Article
Non‐driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 131, doi. 10.1111/ejh.13882
- By:
- Publication type:
- Article
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 779, doi. 10.1111/ejh.13866
- By:
- Publication type:
- Article
Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non‐neoplastic erythrocytosis patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1079, doi. 10.1002/cam4.4958
- By:
- Publication type:
- Article
Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 516, doi. 10.1111/ejh.13236
- By:
- Publication type:
- Article
The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 6, p. 544, doi. 10.1111/ejh.13041
- By:
- Publication type:
- Article
Cytoplasmic DNA accumulation preferentially triggers cell death of myeloid leukemia cells by interacting with intracellular DNA sensing pathway.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03587-x
- By:
- Publication type:
- Article
Richter's Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 1, p. 47, doi. 10.1007/s12185-023-03592-0
- By:
- Publication type:
- Article
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 4, p. 500, doi. 10.1007/s12185-020-03054-x
- By:
- Publication type:
- Article
Interferon therapy for pregnant patients with essential thrombocythemia in Japan.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 1, p. 106, doi. 10.1007/s12185-020-03001-w
- By:
- Publication type:
- Article
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. E128, doi. 10.1002/ajh.24752
- By:
- Publication type:
- Article
Imatinib-sensitive myeloid neoplasm with low allele burden of FIP1L1- PDGFRA fusion gene in an elderly patient.
- Published in:
- Geriatrics & Gerontology International, 2016, v. 16, n. 12, p. 1346, doi. 10.1111/ggi.12733
- By:
- Publication type:
- Article
Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2023, v. 55, n. 2, p. 263, doi. 10.1007/s11239-022-02751-0
- By:
- Publication type:
- Article
Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0202429
- By:
- Publication type:
- Article
Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1 -Negative Myeloproliferative Neoplasms.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 13008, doi. 10.3390/ijms241613008
- By:
- Publication type:
- Article
CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms.
- Published in:
- Cancer Science, 2021, v. 112, n. 2, p. 884, doi. 10.1111/cas.14763
- By:
- Publication type:
- Article